Molecular Targets and Cancer Therapeutics

Co-Head of Theme: Professor Michelle Haber AM

Co-Head of Theme: Professor Murray Norris AM

We focus on developing new approaches to treat the most aggressive forms of childhood brain cancer, leukaemia and neuroblastoma.

For the best chance of survival, it is vital that cancer in a child is detected as early as possible.

improved diagnosis

This involves the identification and validation of new molecular targets, the discovery and optimisation of new drugs or combinations, the development of realistic pre-clinical systems to model clinical activity and ultimately the establishment of clinical trials to test new targeted therapies.